Vaccine efficiency against long COVID measured positively among children and adolescents --two studies

Studies describe vaccine efficacy against long COVID In the first study, published in eClinicalMedicine, researchers measured the real-world efficacy of the Pfizer-BioNTech (BNT162b2) vaccine against long COVID in children and adolescents using data from 20 US health systems collected in as part of the RECOVER PCORnet electronic health record (EHR) Program. CIDRAP

...

Two new large studies, one based on outcomes among US children and teens and the other on adults in Japan, show COVID-19 vaccines are protective against long COVID. Both studies were conducted when the Omicron strain of the virus was dominant, with the first also assessing the Delta variant.

...